RTI Surgical Inc. (RTIX) Trading 3.2% Higher
RTI Surgical Inc. (NASDAQ:RTIX) traded up 3.2% during trading on Tuesday . The stock traded as high as $3.21 and last traded at $3.20, with a volume of 182,928 shares traded. The stock had previously closed at $3.10.
Several equities research analysts recently commented on the stock. Zacks Investment Research lowered shares of RTI Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, June 29th. Craig Hallum lowered shares of RTI Surgical from a “buy” rating to a “hold” rating and cut their price target for the stock from $6.00 to $4.00 in a research note on Thursday, July 28th.
The firm has a market cap of $183.38 million and a P/E ratio of 44.37. The stock has a 50-day moving average of $3.67 and a 200 day moving average of $3.71.
RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Wednesday, July 27th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.08. The business had revenue of $67.60 million for the quarter, compared to the consensus estimate of $66.52 million. During the same period in the prior year, the company posted $0.04 EPS. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, analysts anticipate that RTI Surgical Inc. will post $0.10 earnings per share for the current fiscal year.
A number of large investors have added to or reduced their stakes in RTIX. Royce & Associates LLC increased its stake in RTI Surgical by 30.9% in the fourth quarter. Royce & Associates LLC now owns 1,558,774 shares of the company’s stock valued at $6,188,000 after buying an additional 368,000 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in RTI Surgical by 1.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,595,287 shares of the company’s stock valued at $14,273,000 after buying an additional 44,725 shares in the last quarter. Finally, Paradigm Capital Management Inc. NY increased its stake in RTI Surgical by 17.4% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 4,438,200 shares of the company’s stock valued at $17,620,000 after buying an additional 658,474 shares in the last quarter.
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.